Ulf Meier-Kriesche
Hoofd Techniek/Wetenschap/O&O bij VELOXIS PHARMACEUTICALS A/S
Actieve functies van Ulf Meier-Kriesche
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Hoofd Techniek/Wetenschap/O&O | 13-09-2017 | - |
Loopbaan van Ulf Meier-Kriesche
Opleiding van Ulf Meier-Kriesche
| University of Perugia | Doctorate Degree |
Statistieken
Internationaal
| Denemarken | 2 |
| Italië | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Beurs
- Insiders
- Ulf Meier-Kriesche
- Ervaring
